PIG.F Perrigo Company plc

Healthcare Pharmaceuticals Frankfurt Exchange
14.45 EUR
Close of Nov 13, 2026
7.46 15.19
Market cap
EUR 2.01B
P/E
-
P/B
0.94x
ROE
-19.2%
Dividend yield
6.99%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PIG.F undervalued?

Graham number

The Graham number of Perrigo Company plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Perrigo Company plc fundamental analysis

No fundamental analysis for Perrigo Company plc yet.

Perrigo Company plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-dia…

Full company profile